Testosterone: Functions, Imbalances, and Health Strategies

Testosterone drives far more than sex drive and muscle size. It regulates red blood cell production, bone density, fat distribution, mood, and cognitive function in both men and women, making it one of the most broadly influential hormones in the human body. When levels fall too low or spike too high, the effects ripple across nearly every organ system. The science around testosterone has shifted considerably in the past decade, with new data clarifying old fears about heart disease and prostate cancer, while lifestyle research has sharpened the picture of what people can actually do without a prescription.

What Testosterone Does Beyond the Obvious

Most people associate testosterone with muscle and libido, but its physiological reach is much wider. Testosterone increases muscle mass and maximal voluntary muscle strength, and it improves aerobic capacity by boosting red blood cell production, oxygen delivery, tissue blood flow, and mitochondrial quality.¹ The red blood cell effect is substantial. In clinical studies, testosterone administration raised hemoglobin by roughly 7–10% and hematocrit by a comparable amount, driven by increased erythropoietin (the hormone that tells bone marrow to make more red cells) and suppressed hepcidin (a protein that locks away iron).² This mechanism is so robust that it works independently of dihydrotestosterone, the more potent androgen derivative, meaning the red blood cell boost comes from testosterone itself.³

Testosterone also plays a role in brain function and social behavior. It influences the brain through both long-term structural effects laid down during development and shorter-term activational effects that shift cognition and mood.⁴ Research on social cognition suggests testosterone tends to promote self-oriented and competitive behaviors, sitting in a kind of tug-of-war with oxytocin, which favors prosocial behavior.⁵ That does not mean testosterone makes people aggressive in any simple way. The relationship is far more context-dependent than the pop-culture “roid rage” stereotype implies.

Testosterone in Women

The framing of testosterone as a “male hormone” and estrogen as a “female hormone” is not supported by the science. Androgens, the hormone family that includes testosterone, are actually the most abundant sex hormones in all humans, including women.⁶ In women, testosterone contributes to cardiovascular health, bone remodeling, muscle mass, brain function, and reproduction. The ovaries and adrenal glands both produce it, and levels decline gradually with age, much as they do in men.

When testosterone runs too high in women, the most common clinical picture is polycystic ovary syndrome (PCOS), which affects roughly 5–10% of women. PCOS involves overproduction of ovarian androgens and can cause excess hair growth, acne, irregular or absent ovulation, and infertility. Insulin resistance, often worsened by obesity, is frequently part of the pattern.⁷

When testosterone is too low in women, the main symptom that has drawn clinical attention is low sexual desire. Transdermal testosterone at a dose of 300 micrograms per day has been shown in large trials to improve desire and reduce distress in postmenopausal women with hypoactive sexual desire disorder.⁸ Systematic reviews of this literature confirm consistent benefits across studies, though long-term safety data remain limited.⁹ No testosterone product is currently approved for women in the United States, largely because of that gap in long-term data, which means prescribing happens off-label when clinicians judge it appropriate.¹⁰ Unwanted hair growth is the most common side effect, reported more often with the higher 300-microgram dose.

How Testosterone Is Regulated

The body controls testosterone through a feedback loop between the brain and the testes (or ovaries). The hypothalamus releases a signaling molecule that tells the pituitary gland to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate testosterone production. When testosterone levels climb high enough, the signal feeds back to the hypothalamus and dials down the process. Interestingly, testosterone does not act directly on the neurons that release the initial signal. Instead, it targets a separate group of neurons in the hypothalamus that uses a molecule called kisspeptin to relay the “slow down” message.¹¹

This feedback loop matters for understanding both diagnosis and treatment. When the testes fail, LH climbs because the brain keeps calling for more testosterone that never arrives. When the brain itself is the problem, both testosterone and LH are low. These two patterns define the two main categories of male hypogonadism, and distinguishing between them changes the treatment approach entirely.

When Testosterone Falls Too Low

Male hypogonadism comes in two broad forms. Primary hypogonadism means the testes cannot produce enough testosterone despite the brain’s signals being appropriately elevated. The most common genetic cause is Klinefelter syndrome, which affects about 2 in 1,000 men and is frequently undiagnosed. Secondary hypogonadism means the problem is upstream, in the hypothalamus or pituitary. The most common permanent causes are head and neck radiation and severe head trauma. But the most common potentially reversible causes are obesity, severe illness, and certain medications, particularly opioids and corticosteroids.¹²

The reversibility distinction matters more than most men realize. A man whose testosterone is low because he is carrying significant excess weight or taking chronic opioids may see levels normalize if those underlying factors are addressed, without ever needing testosterone therapy. That possibility is often undertreated in practice.

The Age-Related Decline

Testosterone levels decline progressively with age in men. This gradual drop is associated with changes in body composition, reduced energy and muscle strength, lower sexual function, and shifts in mood and cognition.¹³ The decline tends to become clinically detectable after age 40.¹⁴

The complication is that many older men’s levels, while lower than their personal peak, still fall within the normal range established in younger men. Whether treating those borderline levels produces meaningful benefit is genuinely unclear. “Andropause” is best understood as the point where age-related decline drops testosterone below the young-adult normal range and produces symptoms consistent with deficiency, not simply as an inevitable crisis every aging man faces.

Getting Tested the Right Way

Testosterone follows a daily rhythm. Levels peak in the early morning and drop over the course of the day. In men aged 30 to 40, afternoon levels can run 20–25% lower than early-morning values. That gap narrows with age, shrinking to around 10% in men around 70.¹⁵ In one study, 17 men whose afternoon samples came back below the typical threshold had completely normal readings at all three morning visits, meaning they would have been misdiagnosed as deficient based on timing alone.

For men under 45, morning blood draws remain important. For men 45 and older, the diurnal swing is muted enough that testing before 2 p.m. is acceptable.¹⁶ Both young and middle-aged men still show a significant diurnal pattern, with peak levels arriving between 7:00 and 7:30 a.m.¹⁷ Getting this detail wrong is one of the most common ways a normal man ends up with an unnecessary diagnosis.

Testosterone Replacement Therapy Options

For men with confirmed hypogonadism, several delivery methods exist: topical gels, intramuscular injections, subcutaneous pellets, nasal gels, buccal tablets, and oral pills. Each has trade-offs in convenience, dosing stability, and side effects.¹⁸

Injections produce the highest peak testosterone levels of any formulation, which sounds appealing but comes with a catch: the rate of erythrocytosis (red blood cell counts climbing too high) was roughly 67% in injectable users over three years, compared with about 13% for gels and 35% for pellets. Injections also drove the most elevation in estrogen levels.¹⁹ Gels deliver steadier, more physiological levels with fewer red blood cell issues, but require daily application and carry a risk of transferring testosterone to partners or children through skin contact. Pellets implanted under the skin last several months but require a minor procedure and cannot be easily adjusted once placed.

Metabolic Benefits of Treatment

In men with both low testosterone and type 2 diabetes, testosterone therapy improved insulin sensitivity, lowered fasting blood glucose, and reduced visceral belly fat.²⁰ A separate trial in diabetic men on metformin found that testosterone increased lean body mass by about 1.9 kg and decreased total fat mass by about 1.3 kg, though it did not significantly improve insulin-stimulated glucose disposal in that particular study.²¹ In men with congenital hypogonadism, testosterone replacement produced dramatic improvements in insulin resistance markers alongside significant gains in lean mass and reductions in truncal fat and waist circumference.²²

The metabolic picture is encouraging but not uniform. Benefits are clearest in men who are genuinely hypogonadal, and the body-composition changes (more muscle, less fat) are the most consistent finding across studies. Whether those changes translate into long-term reductions in diabetes complications is still being worked out.

The Heart Safety Question

For years, the biggest concern around testosterone therapy was cardiovascular risk. In the early 2010s, a handful of observational studies triggered FDA advisories, and the question lingered without a definitive answer.²³

The TRAVERSE trial, published in the New England Journal of Medicine, was designed specifically to resolve this. It enrolled over 5,000 men with hypogonadism who already had or were at high risk for cardiovascular disease. Major cardiac events occurred at nearly identical rates in the testosterone and placebo groups: about 7.0% versus 7.3%, confirming that testosterone therapy was not inferior to placebo for cardiac safety.²⁴ The trial did flag higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group, which means therapy is not risk-free even though the headline cardiac scare appears to be settled. A large Veterans Affairs cohort study reinforced this picture, finding no increased composite cardiovascular risk with testosterone use, and in men who already had heart disease, transdermal testosterone was associated with lower risk.²⁵

Prostate Cancer Fears

The idea that testosterone feeds prostate cancer has deep roots in medical thinking, dating back to Nobel Prize-winning research from the 1940s. Modern data tell a different story. The TRAVERSE trial found no significant difference in prostate cancer between testosterone and placebo groups: 12 cases in the treatment group versus 11 in placebo.²⁶ A meta-analysis looking across multiple studies also concluded that prostate cancer appears unrelated to endogenous testosterone levels, and testosterone replacement for symptomatic hypogonadism does not appear to increase PSA levels or the risk of developing prostate cancer.²⁷ The authors note some caution is appropriate until more long-term data accumulate, but the blanket fear that once kept many hypogonadal men from treatment is not supported by current evidence.

Fertility and Testosterone Therapy

Here is something that catches many men off guard: taking testosterone to treat low levels can actually make you infertile. Exogenous testosterone suppresses the brain’s signal to the testes, and without that signal, sperm production can shut down entirely.²⁸ This is the same feedback mechanism that normally keeps hormones balanced, but when the testosterone comes from a gel or injection instead of the testes, the brain reads it as “plenty already” and stops sending the hormones that maintain sperm production.

For men who want to preserve fertility, alternatives like human chorionic gonadotropin (hCG) can stimulate the testes to produce both testosterone and sperm. In a cohort of 77 men who had been on testosterone therapy, about three-quarters showed improved sperm concentrations after treatment with hCG and FSH, regardless of whether they continued testosterone therapy concurrently.²⁹ Any man under about 50 who is considering testosterone therapy should be explicitly asked about his fertility plans before treatment starts. This conversation is skipped too often.

Anabolic Steroid Abuse Is a Different Animal

Prescription testosterone therapy and the doses used in bodybuilding or athletic doping share a molecule but little else. Supraphysiological doses of anabolic-androgenic steroids cause measurable heart damage. A study comparing steroid users with non-users found that users had significantly reduced heart pumping function, with an average ejection fraction of 52% versus 63% in non-users. Users who were actively on steroids at the time of the study fared worse still, at 49%. Steroid users also had more coronary artery plaque, and the amount of plaque tracked with cumulative lifetime steroid use.³⁰

Beyond the heart, anabolic steroid abuse shifts lipids in a dangerous direction (higher LDL, lower HDL), and has been linked with elevated blood pressure, enlarged heart chambers, and in small case series, fatal heart rhythm disturbances and heart attacks in otherwise young, healthy athletes.³¹ These risks are entirely separate from the safety profile of replacement-dose testosterone in genuinely deficient men. Conflating the two has muddied public understanding in both directions: it has scared men away from legitimate therapy and given steroid users false confidence that “it’s just testosterone.”

Lifestyle Strategies That Actually Move the Needle

Weight loss is the single most consistent non-pharmacological lever for raising testosterone. Both moderate and significant reductions in body fat are associated with meaningful increases in serum testosterone, and the effect has been documented with dietary changes, exercise, and bariatric surgery. Among dietary patterns, low-carbohydrate and Mediterranean-style diets have the most evidence behind them. Bariatric surgery, for men who are significantly obese, has produced some of the largest and most durable testosterone increases.³²

Exercise helps, but the specifics matter. Both resistance training and endurance exercise can raise testosterone acutely, but the magnitude varies enormously depending on the type of exercise, intensity, the person’s age and fitness level, and even the timing of the blood draw after the workout.³³ What is clear is that endogenous testosterone is critical for the adaptive response to strength training. When researchers experimentally suppressed testosterone in men undergoing a resistance training program, the training response was significantly blunted, confirming that the hormone is not just a bystander in the process.³⁴

Sleep and stress represent the other two major lifestyle variables. Obstructive sleep apnea in middle-aged men is commonly associated with lower testosterone, though untangling the independent effect of sleep disruption from the confounding effects of obesity and aging has proven difficult.³⁵ One review concluded that the direct effect of sleep restriction on testosterone, independent of changes in binding proteins and co-existing conditions, is on balance tenuous.³⁶ The practical takeaway: treat sleep apnea for the many well-established health reasons, and any testosterone benefit may come along for the ride, but do not expect sleep optimization alone to dramatically change hormone levels.

Stress, Cortisol, and the Hormonal Trade-Off

Chronic stress suppresses testosterone through a well-documented mechanism. Stress hormones (glucocorticoids like cortisol) act at multiple levels of the reproductive axis: they reduce the signaling molecule from the hypothalamus, suppress LH and FSH release from the pituitary, and can directly inhibit testosterone production in the testes or steroid production in the ovaries.³⁷ The stress system and the reproductive system are essentially wired to suppress each other: when the body perceives threat, reproduction gets deprioritized.³⁸

This means that for men with chronically elevated cortisol from work stress, poor sleep, overtraining, or untreated anxiety, there is a plausible biological route by which stress management could support testosterone levels. Whether meditation, therapy, or reduced training volume actually produces measurable hormonal shifts in controlled studies is less well documented than the underlying mechanism. Still, reducing obvious sources of chronic physiological stress is unlikely to hurt and has enough biological justification to be worth prioritizing alongside the more robustly supported strategies of weight loss and exercise.

Environmental Chemicals and Testosterone

Endocrine-disrupting chemicals (EDCs) found in plastics, pesticides, personal-care products, and industrial pollution can interfere with the synthesis and action of sex hormones. Persistent exposure has been linked to reproductive tract abnormalities and declining semen quality.³⁹ The most-studied disruptors include bisphenol A (BPA), phthalates, and certain pesticides. These compounds can mimic estrogen, block androgen receptors, or interfere with the enzymes involved in making testosterone.

The population-level significance of EDC exposure is an active area of debate. Some researchers point to secular trends of declining sperm counts and argue that environmental chemicals are a major driver. Others note that changes in obesity rates, physical activity, and lifestyle could explain much of the trend without invoking chemical exposure. What is not debated is that high-dose occupational exposure to certain EDCs is harmful. For the average person, minimizing exposure through practical steps like avoiding heating food in plastic containers and choosing fragrance-free personal-care products is reasonable, but it would be an overstatement to blame everyday chemical exposure for a given individual’s testosterone level.

The Evolutionary Cost of High Testosterone

There is a longstanding hypothesis in evolutionary biology that testosterone carries an immunological cost. The idea is that higher testosterone suppresses certain immune functions, creating a trade-off: traits favored by sexual selection (muscle, dominance behavior, ornamentation in other species) come at the expense of infection resistance. A study in a forager-horticultural population with high pathogen exposure tested this directly. Men with higher testosterone showed reduced immune cell responses to one type of immune challenge but not to another, suggesting the trade-off is real but more selective than the simple version of the hypothesis predicts.⁴⁰

This trade-off may help explain why men, on average, have slightly weaker immune responses to certain infections compared to women, and why autoimmune diseases are more common in women (whose lower testosterone may leave the immune system less restrained). It also adds an evolutionary frame to the modern clinical observation that very high testosterone levels, whether from steroid abuse or endocrine tumors, tend to come with health costs that go beyond the obvious cardiovascular and hepatic risks.